19-54885426-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002000.4(FCAR):c.262G>A(p.Asp88Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,613,874 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002000.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCAR | NM_002000.4 | c.262G>A | p.Asp88Asn | missense_variant | 3/5 | ENST00000355524.8 | NP_001991.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCAR | ENST00000355524.8 | c.262G>A | p.Asp88Asn | missense_variant | 3/5 | 1 | NM_002000.4 | ENSP00000347714.3 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152060Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000223 AC: 56AN: 251462Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135920
GnomAD4 exome AF: 0.000157 AC: 230AN: 1461814Hom.: 1 Cov.: 33 AF XY: 0.000166 AC XY: 121AN XY: 727220
GnomAD4 genome AF: 0.000138 AC: 21AN: 152060Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74258
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 07, 2022 | The c.262G>A (p.D88N) alteration is located in exon 3 (coding exon 3) of the FCAR gene. This alteration results from a G to A substitution at nucleotide position 262, causing the aspartic acid (D) at amino acid position 88 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at